This compound is a bicyclic nucleoside analog, specifically a derivative of guanosine, characterized by the presence of a methylene bridge between the 2'-oxygen and 4'-carbon atoms of the ribose sugar. It serves as a pharmaceutical intermediate for the synthesis of nucleoside analogs.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 207131-16-6
((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl 4-methylbenzenesulfonate
pharmaceutical intermediate for nucleoside analogs
2'-Deoxy-2'-fluoroguanosine
pharmaceutical intermediate for nucleoside analogs
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
pharmaceutical intermediate for nucleoside analogs
Fmoc-Ala-OH H2O
Fmoc-protected amino acid for peptide synthesis
4-(Cbz-amino)piperidine Hydrochloride
Pharmaceutical intermediate
(2S)-4-[[(TERT-BUTOXY)CARBONYL]AMINO]-2-HYDROXYBUTANOIC ACID
Boc-protected amino acid intermediate
1,8-Bis(dimethylamino)naphthalene
Proton sponge for organic synthesis
2-amino-9-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-1H-purin-6-one
OZVMOEUWPMYRQU-JUQFDLSGSA-N
C1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)CO